rs11573587
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_003738.5(PTCH2):c.2127C>T(p.Asp709Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0182 in 1,613,342 control chromosomes in the GnomAD database, including 335 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 21 hom., cov: 33)
Exomes 𝑓: 0.019 ( 314 hom. )
Consequence
PTCH2
NM_003738.5 synonymous
NM_003738.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.912
Publications
7 publications found
Genes affected
PTCH2 (HGNC:9586): (patched 2) This gene encodes a transmembrane receptor of the patched gene family. The encoded protein may function as a tumor suppressor in the hedgehog signaling pathway. Alterations in this gene have been associated with nevoid basal cell carcinoma syndrome, basal cell carcinoma, medulloblastoma, and susceptibility to congenital macrostomia. Alternatively spliced transcript variants have been described.[provided by RefSeq, Oct 2009]
PTCH2 Gene-Disease associations (from GenCC):
- nevoid basal cell carcinoma syndromeInheritance: AD, Unknown Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- commissural facial cleftInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 1-44827646-G-A is Benign according to our data. Variant chr1-44827646-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 415453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.912 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0142 (2158/152312) while in subpopulation NFE AF = 0.0232 (1578/68024). AF 95% confidence interval is 0.0222. There are 21 homozygotes in GnomAd4. There are 1012 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 2158 AD,Unknown gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PTCH2 | ENST00000372192.4 | c.2127C>T | p.Asp709Asp | synonymous_variant | Exon 15 of 22 | 1 | NM_003738.5 | ENSP00000361266.3 | ||
| PTCH2 | ENST00000447098.7 | c.2127C>T | p.Asp709Asp | synonymous_variant | Exon 15 of 23 | 1 | ENSP00000389703.2 |
Frequencies
GnomAD3 genomes AF: 0.0142 AC: 2158AN: 152194Hom.: 21 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2158
AN:
152194
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0134 AC: 3324AN: 248898 AF XY: 0.0138 show subpopulations
GnomAD2 exomes
AF:
AC:
3324
AN:
248898
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0186 AC: 27180AN: 1461030Hom.: 314 Cov.: 37 AF XY: 0.0184 AC XY: 13340AN XY: 726800 show subpopulations
GnomAD4 exome
AF:
AC:
27180
AN:
1461030
Hom.:
Cov.:
37
AF XY:
AC XY:
13340
AN XY:
726800
show subpopulations
African (AFR)
AF:
AC:
84
AN:
33480
American (AMR)
AF:
AC:
392
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
728
AN:
26136
East Asian (EAS)
AF:
AC:
2
AN:
39700
South Asian (SAS)
AF:
AC:
507
AN:
86256
European-Finnish (FIN)
AF:
AC:
373
AN:
52602
Middle Eastern (MID)
AF:
AC:
18
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
24078
AN:
1111982
Other (OTH)
AF:
AC:
998
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
1784
3568
5352
7136
8920
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
900
1800
2700
3600
4500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0142 AC: 2158AN: 152312Hom.: 21 Cov.: 33 AF XY: 0.0136 AC XY: 1012AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
2158
AN:
152312
Hom.:
Cov.:
33
AF XY:
AC XY:
1012
AN XY:
74482
show subpopulations
African (AFR)
AF:
AC:
162
AN:
41566
American (AMR)
AF:
AC:
182
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
101
AN:
3470
East Asian (EAS)
AF:
AC:
2
AN:
5184
South Asian (SAS)
AF:
AC:
29
AN:
4832
European-Finnish (FIN)
AF:
AC:
70
AN:
10628
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1578
AN:
68024
Other (OTH)
AF:
AC:
33
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
114
228
343
457
571
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
Apr 01, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Basal cell carcinoma, susceptibility to, 1 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Gorlin syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Basal cell nevus syndrome 1 Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.